DR. NUR FADHLINA BINTI ABDUL SATAR
Dean Office
Faculty of Medicine
nina.abdulum.edu.myView CV | |
Publons | |
Scopus Link | |
Biography | |
Dr Nur Fadhlina is an active member of Department of Clinical Oncology University Malaya, being awarded the Excellence Service Award in 2023 by University of Malaya. She completed MRCP(UK) and trained at University College London and Barts NHS Trusts. She subsequently obtained FRCR and Masters in Clinical Oncology under Institute Cancer Research London. She is passionate on issues pertaining to medical education and currently leads the Cancer ECHO UM project, collaborating with industry and cancer centres in Malaysia, running teaching sessions throughout the year. She was the Part 2 Program Coordinator of Master in Clinical Oncology UM from 2021-2023, responsible for coordination of teaching sessions and post graduate examination. She is co-supervisor for a PhD student, carrying out clinical trial in immunonutrition in Head and Neck cancer patients. She is also the Principal Investigator for industry led international clinical trials in Head and Neck and Breast cancers, winning CIC Award for Highest Research Grant procured in 2021. She has actively collaborated with local researchers and industry, publishing results in international journals such as Clinical Oncology, Frontiers in Nutrition and Diagnostics. She won the Japan Society Medical Oncology Rising Star in Asia Workshop Award, and presented work on nasopharyngeal cancer in Fukuoka, Japan in 2023. Dr Fadhlina speaks passionately on public forum, such as Breast Cancer Campaign launched by Breast Cancer Welfare Association 2023 and MOS Cancer Survivorship campaign 2024. She gave talks in ASCOMOS 2021, 2022 and is also the invited panellist for Global Oral Cancer Forum 2024. |
Publication
Finance
Discriminatory Ability and Clinical Utility of the AJCC7 and AJCC8 Staging Systems for Breast Cancer in a Middle-Income Setting
Outcome for recurrent nasopharyngeal carcinoma in Malaysia: University Malaya Medical Centre, 2010-2019
Effects of Immunonutrition in Head and Neck Cancer Patients Undergoing Cancer Treatment - A Systematic Review
Adjuvant breast radiotherapy outcome in older women: A Malaysian experience (The Medical journal of Malaysia)
A phase II, single-arm, open label, Simon two-stage study of pembrolizumab in patients with metastatic HER2-negative breast cancer: Evaluation of impact of germline variants in APOBEC3B (AUROR).